(ASND) Ascendis Pharma complete technical analysis [charts+indicators] | Buy/Sell Ascendis Pharma | (ASND) share price targets
Complete technical analysis of Ascendis Pharma (ASND) by charts plus indicators, forecast predictions and share price targets for Ascendis Pharma (ASND)
Ascendis Pharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-18 View latest technical analysis
10 day averaged volume of Ascendis Pharma is 1484833
| Date | Daily Closing Price | Open | High | Low | Volume |
| 18 Wed Sep 2024 | 148.88 | 146.59 | 150.43 | 145.77 | 0.596 times |
| 17 Tue Sep 2024 | 146.59 | 140.24 | 148.92 | 138.82 | 1.343 times |
| 16 Mon Sep 2024 | 139.57 | 139.65 | 145.00 | 137.75 | 1.962 times |
| 13 Fri Sep 2024 | 119.22 | 116.29 | 119.49 | 114.53 | 0.397 times |
| 12 Thu Sep 2024 | 113.81 | 112.93 | 116.90 | 111.09 | 1.546 times |
| 11 Wed Sep 2024 | 112.93 | 114.19 | 116.11 | 111.23 | 0.511 times |
| 10 Tue Sep 2024 | 114.76 | 116.03 | 119.01 | 113.03 | 0.469 times |
| 09 Mon Sep 2024 | 116.84 | 119.06 | 119.74 | 116.52 | 0.707 times |
| 06 Fri Sep 2024 | 119.15 | 118.99 | 121.25 | 117.40 | 0.421 times |
| 05 Thu Sep 2024 | 119.00 | 122.57 | 126.94 | 118.29 | 0.504 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 142.5, but if it comes below 142.5, then a intra day sell could be more profitable.
If you take a sell trade below 142.5, then use 142.5 as stoploss and 130.75 as target. However if you take a buy trade in stock , then use 142.5 as stoploss and 156.7 as target.
Share price targets for Ascendis Pharma (ASND)
| Target Type | Value |
| Downside Target | 111.09 |
| Downside Target | 115.00 |
| Downside Target | 119.74 |
| Downside Target | 130.57 |
| Downside Target | 137.10 |
| Downside Target | 140.09 |
| Downside Target | 141.22 |
| Downside Target | 142.21 |
| Downside Target | 143.99 |
| Downside Target | 144.62 |
| Upside Target | 150.43 |
Intraday share price targets for Ascendis Pharma (ASND)
| Target Type | Value |
| Downside Intraday Target | 140.94 |
| Downside Intraday Target | 133.01 |
| Upside Intraday Target | 153.62 |
| Upside Intraday Target | 158.37 |
| Downside Intraday Target | 145.69 |
Weekly technical analysis of Ascendis Pharma (ASND)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 18 Wed Sep 2024 | 148.88 | 139.65 | 150.43 | 137.75 | 1.075 times |
| 13 Fri Sep 2024 | 119.22 | 119.06 | 119.74 | 111.09 | 1.035 times |
| 06 Fri Sep 2024 | 119.15 | 136.41 | 138.94 | 115.00 | 23.384 times |
| 30 Fri Aug 2024 | 138.45 | 138.82 | 139.84 | 137.10 | 0.223 times |
| 30 Fri Aug 2024 | 138.45 | 139.83 | 141.22 | 137.10 | 0.461 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Ascendis Pharma (ASND)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 18 Wed Sep 2024 | 148.88 | 136.41 | 150.43 | 111.09 | 1.798 times |
| 30 Fri Aug 2024 | 138.45 | 133.56 | 144.62 | 120.18 | 1.539 times |
| 31 Wed Jul 2024 | 133.50 | 135.68 | 142.21 | 130.57 | 1.008 times |
| 28 Fri Jun 2024 | 136.38 | 135.44 | 140.09 | 121.07 | 0.517 times |
Scroll below to view daily charts
Price has moved up this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Ascendis Pharma (ASND)
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Ascendis Pharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Ascendis Pharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Ascendis Pharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Ascendis Pharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Ascendis Pharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 128.55 and Ascendis Pharma (ASND) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Ascendis Pharma (ASND) stock. Volume based technical analysis of Ascendis Pharma (ASND) stock is negative.
Ascendis Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Ascendis Pharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Ascendis Pharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Ascendis Pharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Ascendis Pharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Ascendis Pharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 128.55 and Ascendis Pharma (ASND) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Ascendis Pharma (ASND) stock. Volume based technical analysis of Ascendis Pharma (ASND) stock is negative.
Ascendis Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.